Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Unique Anti-reflective and Self-cleaning Plastic Films to be Ramped Up for Industry Use

Published: Monday, August 06, 2012
Last Updated: Sunday, August 05, 2012
Bookmark and Share
Scientists from A*STAR's IMRE will partner companies to develop, prototype and conduct pilot large scale manufacturing of nanoimprinted materials with better performance and at potentially lower cost than current production methods.

Fast, high-volume production of plastics with specially engineered surfaces will soon be available using a cheaper and simpler method.

IMRE and its Industrial Consortium On Nanoimprint (ICON) partner companies are piloting roll-to-roll nanoimprint technology to mass produce two types of patterned nanoimprinted plastic films.

These are films with low reflectivity and better viewing angles, as well as durable, scratch-resistant films with 'self-cleaning' surfaces.

This technology can be more cost effective than conventional batch production as ICON uses roll-to-roll processing, which enables the continuous, high throughput production of such materials on a large scale.

Potential applications of such mass-produced anti-reflective films are in the mobile device and tablet markets while the self-cleaning plastics can be applied to surfaces such as walls of buildings.

IMRE and five companies, namely, Innox Higa Singapore Pte Ltd, Micro Resist Technology GmbH, NTT Advanced Technology, SABIC Innovative Plastics and Solves Innovative Technology will work together to develop the materials and scale up production of the films.

Nanoimprinting technology involves creating arrays of very tiny, nano-sized surfaces to form unique patterns that give the surfaces certain properties such as low reflectivity, super-hydrophobicity (water repelling), non-sticky adhesiveness or anti-bacteria qualities.

In this collaboration, the partners are developing tougher resins for the nanostructures that are then patterned onto the plastics via IMRE's unique nanopatterning processes.

The process is then easily scaled up using ultraviolet roll-to-roll nanoimprinters so that the films can be used in eventual prototyping on surfaces and devices.

"The partnership with industries to advance the technology towards scale-up will bring nanoimprinting technology a step closer to full industry adoption," said IMRE scientist Dr Low Hong Yee adding that one of the goals of ICON has been to nurture nanoimprint technology from a primarily laboratory-based process to one with industrial manufacturing and consumer application potential.

"Nanoimprinting is a very versatile and extraordinary technology that turns ordinary surfaces into functional ones. It is also encouraging to see the translation from science to large-scale manufacturing in such a short span of time," said Prof Andy Hor, Executive Director of IMRE.

"We are a company that specializes in photoresists and polymers for micro and nanolithography. Within the ICON project, we will provide tailor-made polymer materials for nanostructured functional films. It is a unique opportunity for us to adapt materials specifically for roll-to-roll processes as well as for "hard" industrial requirements which cannot be achieved by today's off-the-shelf materials. This will strengthen Micro Resist Technology's market business prospects as global supplier of materials for next-generation lithography and nanolithography," said Dr Marko Vogler, Business Unit Manager, Nanoimprint Materials and Hybrid Polymers, Micro Resist Technology GmbH, Germany.

"SABIC Innovative Plastics is excited to be part of this ICON project. It is a unique platform provided by IMRE for us to access advanced nanoimprint technology and enhance our core competencies to provide innovative solutions to our customers and end users in various market segments," said Dr Mahari Tjahjadi, Technology Director, Specialty Film & Sheet, SABIC Innovative Plastics.

"This is a very exciting time for us from the perspective of a local company. Since being involved in the pioneering development of cutting edge technology can put us on the global map, Solves is ready to support mass production using nanoimprint technology!" said Mr Koh Teng Hwee, Managing Director of Solves Innovative Technology, a local small and medium enterprise (SME) that helped co-develop the UV roll-to-roll tool with the IMRE team.

The pilot manufacturing project will last a year after which the consortium can further develop and market the technology.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Understanding and Improving the Body's Fight Against Pathogens
A*STAR scientists find new targets for modulating antibody response.
Tuesday, September 02, 2014
High Capacity Antibody Purification
Researchers from the A*Star Bioprocessing Technology Institute have used magnetic nanoparticles to break the capacity barrier for antibody purification.
Sunday, August 17, 2014
A*STAR Scientist Alex Matter Awarded Prestigious Szent-Gyorgyi Prize For Progress In Cancer Research
National Foundation for Cancer Research honours Professor Alex Matter with esteemed award for groundbreaking cancer pill that gives leukaemia patients a new lease of life.
Friday, April 05, 2013
Scientific News
Envigo Rat Models Proven to be Susceptible to Intra-Vaginal HSV-2 Infection and Protectable
Scientific findings establish the effectiveness of new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection.
Drug that Activates Innate Immune System Identified
Researchers from the institute have identified a drug, which is straightforward to synthesize and to couple to antigens that induce an immune response and may prove useful in the generation of vaccines.
Valvena, GSK Sign New R&D Collaboration
Valneva to supply process development services for EB66® -based Influenza vaccines.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Protein Protects Against Flu in Mice
The engineered molecule doesn’t provoke inflammation and may hail a new class of antivirals.
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!